Abstract

Renal cell carcinoma (RCC) is the most frequent urological malignancy in adults and has a male preponderance. It accounts for approximately 3% of adult malignancies and 90%#x2013;95% of neoplasms arising from the kidney. Metastases have been reported to develop 17 or more years after the primary lesion is removed1. Most cases invade peri-nephric fat